You have landed on a page of the archived Cochrane Community website. This site is not being maintained or updated.

If you are looking for Cochrane Review evidence, please visit Cochrane’s evidence page.

If you are a Cochrane contributor looking for Community resources, please visit the new Cochrane Community website.

Stem cell therapy for chronic ischaemic heart disease and congestive heart failure

Warning: Parameter 2 to onepixelout_swftools_flashvars() expected to be a reference, value given in module_invoke() (line 476 of /var/www/archive/includes/

To browse Podcasts by topic, please visit the new Cochrane Summaries site here

Ischaemic heart disease is the main cause of heart failure, and a leading cause of death. There is an ongoing search for effective treatments, and the use of bone marrow stem cells is a novel therapy that might help. Enca Martin-Rendon from NHS Blood and Transplant and the University of Oxford and others published their Cochrane Review of the topic in April 2014, and she describes the latest evidence in this podcast.

Play Now!

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Download [mp3]  | Read Review
Updated on: April 29, 2014, 14:53

Comments for improvement or correction are welcome.